No clinically relevant differences between positron emission tomography (PET) reconstructions based on low-dose or contrast-enhanced CT in combined integrated multiphase F-18-Fluorethylcholine PET/CT for prostate cancer

Florian F. Behrendt, Carina Lensing, Sebastian Keil, Felix M. Mottaghy, Frederik A. Verburg*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)498-505
JournalJournal of Medical Imaging and Radiation Oncology
Issue number4
Publication statusPublished - Aug 2016


  • contrast medium
  • PET/CT
  • prostate cancer
  • staging
  • SUV

Cite this